Originally published by BBC News. 

More than half a billion pounds will be invested in a new biological defence laboratory at a UK base.

The U.S. Naval Research Laboratory (NRL), in partnership with the Defense Threat Reduction Agency (DTRA) and multiple Army and Navy research commands, has advanced a new generation of DNA and RNA sequencing technology designed to quickly identify biological threats in the field.

The

A man from Greater Manchester, UK, has been charged with producing ricin.

Callum Browne, from Salford, has been charged under the 1996 Chemical

ForgeFX Simulations has been awarded a U.S. Army subcontract to expand access to its CBRN drone pilot training simulator, used to train Army Unmanned Aerial System (UAS) pilots to detect airborne biological threats. Under the program,

In a story in Sputnik, it is reported that Russia's investigative committee has obtained evidence of the development of biological weapons of mass destruction involving Ukraine’s Health Ministry and funded by the United States, the agency’s official spokesperson Svetlana Petrenko

Originally published by https://www.vademec.ru/

The Russian government has ordered Rospotrebnadzor to allocate 409.1 million rubles from the federal budget in 2026 for two capital construction projects that

Battelle has been awarded the Defense Threat Reduction Agency’s (DTRA) Scientific and Technical Engagement Partnership (STEP) 2.0 contract, becoming the sole awardee for this major ...

Originally published by www.ktnv.com

MRIGlobal is proud to have served as prime contractor on development of two new Portable

SIGA recently published an article in The Parliament magazine talking about how as the EU develops its medical countermeasures and stockpiling strategy, it is vital to include both vaccines and antivirals to quickly respond to future outbreaks. SIGA explores why smallpox still poses a danger

On July 24, 2024, the Department of Defense (DOD) fulfilled the final Fiscal Year (FY) 2024 delivery of 626,870 doses of the U.S. Food and Drug Administration (FDA)-approved BioThrax® (Anthrax Vaccine Adsorbed), a pre-exposure prophylaxis (PrEP) for anthrax disease. This marks the completion of

French police are investigating a suspicious letter sent to the interior minister that tested positive for yersinia pestis. 

The letter, unstamped, and with undisclosed “inscriptions” on the back, roused suspicions among workers. Inside, they discovered a black powder and a letter

Originally published by Medpage Today. 

The CDC says a glitch in its bird flu test hasn't harmed the agency's outbreak response, but it has ignited scrutiny of its go-it-alone approach in testing for emerging pathogens.

The agency has quietly worked since April to resolve a

Originally published by Robert Herriman in Outbreak News Today. 

Plague is endemic in Ituri province of the Democratic Republic of the Congo (DRC) where cases are regularly reported in some health zones

One of the challenges faced by many early academic and small business research partners is the cost associated with demonstrating a therapeutic candidate’s effectiveness in relevant efficacy models. BARDA invites researchers to submit proposals to the Botulinum Neurotoxin (BoNT) Candidate

The current generation of large language models (LLMs)—a form of artificial intelligence (AI)—do not increase the risk of a biological weapons attack by a non-state actor, according to new RAND ...

A new study reports 309 lab acquired infections and 16 pathogen lab

BARDA has selected Advanced Technology International (ATI) as the new Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) management firm. The BioMaP-Consortium is a new 10-year program to improve domestic capabilities to manufacture and deliver vital medical

 First Light Diagnostics announced that the US Food and Drug Administration (FDA) has cleared its SensiTox® B. anthracis Toxin Test to be marketed in the U.S.

B. anthracis, the agent that causes anthrax, is a top biodefense concern due to the ease of widespread

A national team of experts will advance an innovative biopolymer particle-based platform technology to develop vaccine candidates to protect against biowarfare threats including Q Fever, tularaemia, and melioidosis.

Health Security Systems Australia (HSSA) is engaging with leading

AI Platform Will Alert Warfighters of Probable Exposure Before Symptoms Emerge

AiRANACULUS®, a private, Massachusetts-based technology company providing state-of-the-art Artificial Intelligence (AI) and Machine Learning (ML) solutions, announced that it has received a U.S.

The Russian region of Voronezh has declared an emergency over a recent anthrax outbreak. One person has been diagnosed with anthrax, presumably cutaneous, as it was contracted from the carcass of an infected animal. 

The governor of the region, Alexander Gusev, declared a

.Health Security Systems Australia (HSSA) is working with experts at the University of Melbourne at the Peter Doherty Institute for Infection and Immunity (Doherty Institute), The University of Queensland’s National Biologics Facility, and industry partner Biointelect Pty Ltd to develop a novel

Emergent BioSolutions Inc. announced on July 20, 2023 that the U.S. Food and Drug Administration (FDA) has approved CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted), previously known as AV7909, for post-exposure prophylaxis of disease following suspected or confirmed exposure

Evotec SE recently announced that the U.S. Department of Defense (“DOD”) has awarded Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to $ 74 m for the rapid development of monoclonal antibody (“mAb”)-based drug product prototypes targeting

Originally published in The Spectator (printed in full because we think it deserves to be known!)

That a pandemic caused by a bat coronavirus started in the city with the world’s largest programme of research into bat coronaviruses was always intriguing. That among the first people to

(Stockholm, 4 April 2023) There is an urgent need to understand how a range of emerging ecological challenges could trigger catastrophic instability and insecurity, argues a new report published today by SIPRI. 

Five Urgent Questions on Ecological Security

Pascale Ferrier, of Quebec, has plead guilty to sending a threatening letter containing ricin to Donald Trump at the White House when he was president. 

On Sunday January 8th, news emerged that police in Germany had arrested a 32 year old Iranian man on suspicion of planning a terrorist act. 

orginally published by https://www.globenewswire.com/

Emergent BioSolutions Inc. (NYSE:EBS) announced today a research award by the U.S. Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP) to evaluate

Evotec SE have announced that the U.S. Department of Defense (“DOD”) has awarded Evotec’s Seattle-based subsidiary, Just – Evotec Biologics, Inc. a contract valued up to $ 49.9 m for the rapid development of monoclonal antibody (“mAb”)-based drug product prototypes targeting plague. Plague, an

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, today announced the exercise of procurement options under its 75A50118C00019 (19C) contract with the U.S. Department of Health and Human Services for the delivery to the U.S. government of intravenous (IV) formulation of

Infection from the enterohemorrhagic E. coli (EHEC) can cause bloody diarrhea and severe abdominal cramps in humans. This is due to the presence of a deadly toxin called “Shiga toxin” (Stx) produced by EHEC. Researchers from Japan have now discovered a compound that binds to and

DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively by the U.S. Department of Defense, U.S. Homeland Security, law enforcement, first responders and public health agencies around the world, today announce the launch of their MD-Bio

Swiss biotech Fastox Pharma will present for the first time its groundbreaking long-lasting botulinum toxin LAST technology at the leading conference on neurotoxins from July 27thto July 30th in New Orleans, USA.

Fastox has discovered that combining botulinum toxin type A (BoNT/A) with

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) awarded a total of $4,479,195.95 in competitive research contracts to 30 small businesses across the United

DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has announced the first successful qPCR assays using primers and probes synthesized by a customer via enzymatic synthesis using the company’s ...

The UK Health Security Agency (UKHSA) has declared a national incident after routine surveillance of wastewater in north and east London found

The UK Health Security Agency has announced today it recommends offering the smallpox vaccine Imvanex, which is shown to be effective against monkeypox, to those considered to be at higher risk of exposure.

Anyone can contract monkeypox, but ...

Teledyne FLIR Defense announced today at Eurosatory the launch of its new MUVE™ B330 drone payload that can be used to detect deadly biological agents and other airborne biohazards.

The MUVE

A story that is hard to miss, and is being reported on globally, is that of the current Monkeypox outbreak.

In a ...

Chimerix, a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announces it has entered into a definitive agreement with Emergent BioSolutions Inc. (Emergent) to acquire its exclusive

SIGA Technologies, Inc. (SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the U.S. Food and Drug Administration (FDA) approved the intravenous (IV) formulation of TPOXX for the treatment of smallpox. The IV formulation is an important

BioFlyte, a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced that it raised $6.1M in new financing led by Cottonwood Technology Fund with additional funding from existing

Heat Biologics, Inc.(to be renamed “NightHawk Biosciences”), a fully-integrated biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced it has completed the acquisition of Elusys

Originally published by Yale School of Health

Masks, physical distancing, good hygiene, and ventilation can help reduce the transmission of COVID-19 in public places. But even when these measures are taken, scientists have sometimes detected SARS-CoV-2, the virus that causes COVID-19,

Scientists from Lawrence Livermore National Laboratory (LLNL) and three other institutions are seeking to develop a multi-pathogen vaccine that will protect against three bacterial biothreat pathogens.

In a time of daily confusion in the public discourse on the current pandemic, the Janne E. Nolan Center on Strategic Weapons, an institute of the Council on Strategic Risks (CSR), is releasing ...